{"schema_version":"1.0","type":"article","title":"AI 一小時做完實驗？Google Co-Scientist 真正跨過的，是「動手」這一關","url":"https://drugnews.com.tw/articles/2026-09-11-google-coscientist-real-world-lab-loop.html","markdown_url":"https://drugnews.com.tw/articles/2026-09-11-google-coscientist-real-world-lab-loop.md","lang":"zh-Hant","date":"2026-09-11","publish_at":"2026-09-11T08:00:00+08:00","updated_at":"2026-09-11","category":"商業分析系列","topic":"商業分析系列","tags":["Google Co-Scientist","AI for Science","Gemini","實驗自動化","研究基礎設施"],"summary":"Google Co-Scientist 從假說生成走向實驗執行，但真正的採購與產業價值仍取決於設備整合、可重現性、失敗紀錄與責任治理。","key_points":[],"facts":[],"sections":[],"references":[],"images":[{"alt":"圖 1｜AI 已接上實驗台，但人仍在責任鏈","url":"https://drugnews.com.tw/assets/articles/google-coscientist-real-world-lab-loop/01_AI%E6%8E%A5%E4%B8%8A%E5%AF%A6%E9%A9%97%E5%8F%B0_typed_v1.png"},{"alt":"圖 2｜研究閉環：構思、執行、驗證與可追溯紀錄","url":"https://drugnews.com.tw/assets/articles/google-coscientist-real-world-lab-loop/02_%E7%A0%94%E7%A9%B6%E9%96%89%E7%92%B0_typed_v1.png"},{"alt":"圖 3｜自主程度不同；濕實驗仍是 human-in-the-loop","url":"https://drugnews.com.tw/assets/articles/google-coscientist-real-world-lab-loop/03_%E8%87%AA%E4%B8%BB%E7%A8%8B%E5%BA%A6_typed_v1.png"},{"alt":"圖 4｜可驗證導入場景：重現、稽核與責任","url":"https://drugnews.com.tw/assets/articles/google-coscientist-real-world-lab-loop/04_%E6%8E%A1%E8%B3%BC%E6%B1%BA%E7%AD%96_typed_v1.png"}],"cover_image":"https://drugnews.com.tw/assets/articles/google-coscientist-real-world-lab-loop/01_AI%E6%8E%A5%E4%B8%8A%E5%AF%A6%E9%A9%97%E5%8F%B0_typed_v1.png","publisher":{"name":"Drugnews｜藥時事","url":"https://drugnews.com.tw/","profile":"https://drugnews.com.tw/brand-profile.json"},"citation":"Drugnews｜藥時事（2026-09-11）。AI 一小時做完實驗？Google Co-Scientist 真正跨過的，是「動手」這一關。https://drugnews.com.tw/articles/2026-09-11-google-coscientist-real-world-lab-loop.html","disclaimer":"本文僅供產業研究與知識分享，不構成投資、醫療、募資或個股建議。","translations":{},"relationship":"independent_editorial","disclosure_url":"https://drugnews.com.tw/policy/"}